Shree Ganesh Remedies Ltd, established in 1995, is a pharmaceutical company based in Ankleshwar, Gujarat. Their primary focus is on the manufacturing and distribution of drug intermediates and specialty fine chemicals for the pharmaceutical industry. They specialize in producing a wide range of products, including amine hydrochloride and other chemicals used in antipsychotic, antiseptic, deprotonation reactions, hyperlipidemia, Alzheimer’s, and anti-viral treatments.
The company caters to both domestic and international markets, with a strong emphasis on exporting their products. They have three manufacturing plants, namely Plant I, II, and III, which are situated on a total area of 9,715 square meters. Each plant is equipped with specific manufacturing capabilities and processes to produce the diverse range of pharmaceutical products. Company is committed to maintaining high-quality standards and serving the global pharmaceutical industry with their reliable and effective drug intermediates and specialty fine chemicals.
Shree Ganesh Remedies IPO Details
| IPO Date | Sep 28, 2017 to Oct 5, 2017 |
| Listing Date | Oct 13, 2017 |
| Face Value | ₹10 per share |
| Price | ₹36 per share |
| Lot Size | 3000 Shares |
| Total Issue Size | 2,376,000 shares (aggregating up to ₹8.55 Cr) |
| Issue Type | Fixed Price Issue IPO |
| Listing At | BSE SME |
Shree Ganesh Remedies IPO Tentative Timetable
IPO opens on Sep 28, 2017, and closes on Oct 5, 2017.
| Event | Tentative Date |
| Opening Date | Sep 28, 2017 |
| Closing Date | Oct 5, 2017 |
| Basis of Allotment | Oct 10, 2017 |
| Initiation of Refunds | Oct 11, 2017 |
| Credit of Shares to Demat | Oct 12, 2017 |
| Listing Date | Oct 13, 2017 |
| UPI Mandate Confirmation Cut-Off Time | 5.00 PM on the issue closing day |
Industry Overview
The industry is driven by various factors such as increasing global population, rising healthcare needs, advancements in medical technology, and growing prevalence of diseases. Companies like Shree Ganesh Remedies play a crucial role in the pharmaceutical supply chain by providing essential ingredients for drug manufacturing.
In terms of industry growth, the compound annual growth rate (CAGR) of the pharmaceutical industry has been positive over the years. However, it’s important to note that specific CAGR figures can vary depending on the market segment and geographic region.
Objects of the Issue
Company proposes to utilize the proceeds from the public issue towards the following objects:
1. Setting up a new Choloro Compound derivatives manufacturing plant with a proposed capacity of 200 MTPA at Ankleshwar GIDC Gujarat;
2. General Corporate Purposes
Shree Ganesh Remedies IPO Prospectus
Company Contact Information
Shree Ganesh Remedies Ltd
Plot no. 6011, G.I.D.C,
Ankleshwar – 393002
Phone: 02646 227777
Email: investors@ganeshremedies.com
Website: http://www.ganeshremedies.com/
Shree Ganesh Remedies IPO Registrar
Bigshare Services Pvt Ltd
Phone: +91-22-6263 8200
Email: ipo@bigshareonline.com
Website: https://www.bigshareonline.com/
Shree Ganesh Remedies IPO Lead Manager(s)
- Fedex Securities Limited (Past IPO Performance)
